Tiagabine Hydrochloride Tablet
Product Images NDC 72205-084

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tiagabine Hydrochloride (NDC 72205-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-30s-cntr-label (12mg 30s Cntr Label)

This is a description of a medication, Tiagabine Hydrochloride, that comes in a package of 30 tablets with the National Drug Code (NDC) of 72205-086-30. The medication guide must be given to each patient upon dispensing. The tablets contain 12mg of USP Tiagabine and should be stored at room temperature. It is distributed by Novadoz Pharmaceuticals LLC in Piscataway, New Jersey, and is manufactured by WSN Laboratories Private Limited in Telangana, India. The usual dosage is available on the package insert.*

FDA Label Image

16mg-30s-cntr-label (16mg 30s Cntr Label)

This is a description for a medication that comes in a bottle with 30 tablets of 16mg dosage of Tiagabine Hydrochloride USP. The usual dosage is not readable from the text, but it is recommended to check the accompanying insert or full dosing instructions. The tablets protect from light and moisture, and it should not be accepted if the seal over the bottle opening is broken. Dispensing the medication should be done in a tight, airtight, and break-resistant container. It comes with a medication guide to distribute to each patient. This medication is distributed by Novadoz Pharmaceuticals LLC, located in Piscataway, NJ 08854-3714, and it is a prescription-only drug.*

FDA Label Image

2mg-30s-cntr-label (2mg 30s Cntr Label)

This is a description of a medication called Tiagabine Hydrochloride. The medication comes in the form of 30 tablets, with each tablet containing 2mg of the drug. The product has an NDC number of 72205-084-30. The usual dosage is available in the package insert. The medication is manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. The text also provides instructions for storage and disbursement of the medication.*

FDA Label Image

4mg-30s-cntr-label (4mg 30s Cntr Label)

This is a medication description for Tiagabine Hydrochloride tablets, with a dosage of 4mg. The package contains 30 tablets and comes with a medication guide to be given to each patient. The recommended dosage can be found in the package insert with the full prescribing information. The medication should be stored at room temperature and the bottle should not be used if the seal is broken or missing. The tablets are manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ.*

FDA Label Image

Fig-1 (Tiagabine Fig 1)

The text shows a graph (Figure 1) that represents the % Reduction in Partial Seizure Rate. There are two studies compared represented by blue and red lines, respectively. The x-axis shows the % of patients, from -250% to 100%, and the y-axis shows the percentage of improvement, no change, or worsening of the seizure rate. Two treatments, Tiagabine Hydrochloride 32-+56 mg/day and Placebo, are compared on this graph.*

FDA Label Image

Fig-2 (Tiagabine Fig 2)

The text is describing a graph or figure that shows four different treatments for partial seizures in a study (labeled as Study 1). The treatments are placebo, Tiagabine Hydrochloride at 16 mg/day, 32 mg/day, and 56 mg/day. The graph displays the percentage of patients who experienced improvement, no change, or worsening of their seizures, with a maximum improvement of 100% of patients.*

FDA Label Image

Fig-3 (Tiagabine Fig 3)

The text describes a figure displaying the % reduction in partial seizure rate from Study 2. It shows the results of different medication dosages, including a placebo, Tiagabine Hydrochloride 8mg QID and Tiagabine Hycrochlorde 16 mg BD. The figure shows the percentages of patients with improved, unchanged, and worsened conditions.*

FDA Label Image

Fig-4 (Tiagabine Fig 4)

FDA Label Image

Tia-str (Tiagabine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.